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INTRODUCTION
 Benzodiazepines are commonly prescribed drugs used to treat insomnia and anxiety. They 
are often found in forms such as Xanax (alprazolam) and Valium (diazepam). For many, these 
drugs have proven essential for ensuring a restful night’s sleep, but for others they are the cause of 
sleepless ones. Negative effects of benzodiazepines such as addiction, dependence, and impaired 
cognition plague many patients.  While doctors are prone to prescribe these medications readily 
due to their high level of effectiveness, this practice can pose a great risk to certain populations .
Structure of Benzodiazepines
 Benzodiazepines consist of a benzene ring and diazepine ring (see 
fig 1). Varying side chains which attach to this basic structure account for 
the various drugs formed from this compound. Xanax (alprazolam), Li-
brium (chlordiazepoxide), Klonopin (clonazepam), Tranxene (clorazepa-
te), Valium (diazepam), Paxipam (halazepam), and Ativan (lorzepam) are 
prescribed for long term use while ProSom (estzolam), Dalmane (fluraz-
epam), Doral (quazepam), Restoril (temazepam), and Halcion ( triazolam) 
are prescribed specifically for short term use. 
Mechanism of Action
 GABA is the primary inhibitory neurotransmitter of the central nervous system. GABA 
receptors exist in two forms, GABAA and GABAB.  GABAA receptors (GABAAR) are present 
on neuron membranes and work as ligand-gated ion channels. When GABA binds to GABAA re-
ceptors, the flow of chloride ions into the cell increases. The influx of negatively charged chloride 
ions causes the cell to undergo hyperpolarization. In turn, the transmission of action potentials is 
less likely to occur, and neurotransmission is inhibited. 
 GABAA receptors are found as part of a protein complex. This complex also houses differ-
ent allosteric binding sites which can indirectly affect GABAA when activated.  Benzodiazepine 
can bind to one of the allosteric sites on this complex. When benzodiazepine binds to its receptor 
on the protein complex, it causes the GABAA receptor to experience a conformational change. 
This change locks the GABAA receptor in a form to which GABA has a higher level of affinity. 
This results in an even greater influx of chloride ions than would normally be triggered by the 
binding of GABA. In this way, benzodiazepines work as an agonist of GABAA and slow down the 
brain and nervous system . 
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 Benzodiazepines are most often associated with the treatment of insomnia and anxiety. 
Insomnia is a sleeping disorder causing difficulty in sleeping or falling asleep. Anxiety often ac-
companies depression or other psychological disorders and is characterized by excessive stress, 
worry, or fear. The ability of benzodiazepines to inhibit brain activity and neurotransmission helps 
to promote sleep and relaxation, and induces a calming effect. Benzodiazepines are also used to 
treat muscle spasms, convulsive disorders, and to induce sedation prior to surgery. Further uses of 
benzodiazepines are listed in the tables below. 
. 
 
Table 1. Benzodiazepines are used to treat a myriad of ailments. 
The Effectiveness of Benzodiazepines in the Treatment of Insomnia
 Benzodiazepines have been established as an effective treatment for insomnia. In an analy-
sis of twenty-two studies of benzodiazepines and benzodiazepine-receptor agonists, significant 
improvements were found in total sleep time, number of awakenings, and sleep quality of the treat-
ed patients. However, only nine of those studies contained information complete enough to allow 
for accurate calculation of effectiveness.  The nine studies analyzed involved a total sample of 343 
patients who were treated with benzodiazepines and 337 who were members of control groups. 
All participants fell between the ages of 18 and 65. Participants who received the medication fell 
asleep sooner than 71% of the control group slept longer than 76% of the control group, woke up 
less often than 74% of the control group, and had better sleep quality than 73% of the control group. 
All of the studies examined in this meta-analysis used a “placebo –control group, parallel-group 
design, randomized patient assignment, and double-blind assessment of outcomes.”(Nowell, et al., 
1997)
 An additional study was conducted on 54 patients who were prescribed benzodiazepines. 
The participants of the study were of sixty-five years of age or older and were at the hospital dur-
ing the three day study period. Thirty one of the patients had not used benzodiazepines previously. 
 Clinical Uses of Benzodiazepines 
Anxiety disorders 
Acute anxiety 
Generalized anxiety disorder 
Panic disorder 
Phobias (social, simple) 
Post-traumatic stress disorder 
Obsessive-compulsive disorder 
Insomnia 





Acute status epilepticus 
Neonatal seizures or febrile convulsions 
Preeclampsia 
Tetanus 
Adjunct to other anticonvulsants 
Amnestic (before surgery or procedure) 
Spastic disorders and other types of acute muscle spasm 
Cerebral palsy 
Multiple sclerosis 
Paraplegia secondary to spinal trauma 
Involuntary movement disorders 
Restless leg syndrome 
Akathisia associated with neuroleptic use 
Choreiform disorders 
Myoclonus 
Detoxification from alcohol and other substances 
Agitation or anxiety associated with other psychiatric conditions 
Acute mania 
Psychotic illness 
Anxiety associated with depression 
Impulse control disorders 
Catatonia or mutism 
Other adjunctive uses 
Surgery 
Dentistry 
Diagnostic studies, such as 
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Half of these patients reported shorter sleep onset while taking the medication at the hospital. In 
other areas of sleep assessment, such as duration of sleep, number of awakenings, and sleep qual-
ity, many had an improved sleep experience in the hospital compared with their sleep at home. 
However, little difference in sleep improvement was observed between those who were newly in-
troduced to benzodiazepines and those who were already using them prior to entering the hospital. 
This indicates that the improvement in sleep which the patients experienced could be attributed to 
the hospital environment or other factors rather than to the prescription of benzodiazepine medica-
tions. While the outcome of this study does not support the effectiveness of benzodiazepines, it 
was conducted on a relatively small group and for a short period of time. These factors limit the 
value of this study and its conclusions .
Risks Associated With Benzodiazepine Use
 While benzodiazepines are considered to be one of the safest sedatives, their use is some-
times accompanied by side effects which can put a patient at risk. Patients most commonly found 
to be at risk are those who take benzodiazepines for extended periods of time, who abuse other 
substances, and those who are elderly.
Dependency & Withdrawal
 According to the FDA fast-onset, short acting benzodiazepines should be prescribed for 
only five consecutive weeks in order to avoid the risk of dependency. In reality, however, they are 
often used for longer periods of time which can lead to complications.  Millions of Americans have 
inadvertently become dependent on benzodiazepines as a result of receiving repeated prescrip-
tions over time. Of the estimated 1 million users in the United Kingdom and 4 million users in the 
United States, 50% are thought to be dependent on benzodiazepines. 
Tolerance as a result of prolonged exposure 
 Tolerance is defined as “a need for markedly increased amounts of the substance to achieve 
the clinical effect, or markedly diminished effect with continued use of the same amount of the 
substance.”  For those who use benzodiazepines to promote sleep, tolerance can develop relatively 
quickly. Dependency can increase within a few short days or weeks. Many of those who use ben-
zodiazepines to induce sleep tend to gradually increase their doses beyond recommended levels. 
Patients may pressure their doctors to increase their prescriptions or perhaps visit multiple doctors 
or clinics to obtain numerous prescriptions simultaneously. Sometimes patients may even turn to 
street drug dealers to obtain the doses they crave. Such practices put users at further risk of becom-
ing dependant on the drug. 
Withdrawal
 Withdrawal symptoms associated with discontinued use of benzodiazepines include “rest-
lessness, irritability, insomnia, muscle tension, weakness, aches and pains, blurred vision, and 
heart racing.” Many continue to take benzodiazepines in order to avoid going through a with-
drawal stage. However, continuing to take the drug may cause patients to become increasingly 
dependent and may dull the drug’s ability to provide relief. 
 In cases where users are not using benzodiazepines for recreational use, the negative ef-
fects experienced upon discontinuation are usually a result of relatively low-dose benzodiazepine 
dependence. However, even when administered at low dosages, long term exposure can result in 
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dependence and negative withdrawal symptoms. With longer-acting drugs, one or two months of 
exposure can put a patient at risk. With shorter-acting drugs, taking the drug daily for a week can 
affect the patient. Short-acting benzodiazepines have also been proven to cause rebound insomnia 
which negatively affects the user’s sleep the night after the drug is used. 
 Drugs which have slower elimination such as Xanax and Valium are more likely to cause 
side effects because metabolites accumulate in the body if the drug is used repeatedly. However, 
users of these drugs are less likely to suffer from withdrawal.  On the other hand, drugs such as 
Doral and ProSom, which have shorter half-lives and elimination time, are more likely to cause 
withdrawal symptoms. 
 Long-term or high-dose exposure to benzodiazepines results in a decrease in the effective-
ness of the body’s natural GABAA. It is thought that continuous administration of the drug causes 
the body to adapt to presence of the drug. When the drug is removed, the forces to which it is nor-
mally opposed are left with no adversary. In the case of benzodiazepines which are used to treat 
anxiety and induce sleep, abrupt discontinuation can cause a surge in nervous activity. 
 While the exact mechanism responsible for benzodiazepine dependence has not been found, 
theories have been proposed and studies have been done which may provide an answer, at least in 
part. Benzodiazepines serve as an agonist of GABAA. When a drug which works as an agonist is 
administered chronically, it causes a decrease in the number of receptors found in the body. This 
is known as down regulation. The receptors are decreased by means of internalization, degrada-
tion, or recycling of the receptor.  A decrease in receptors would then cause the drug to become 
less effective as well as decrease the body’s ability to respond to its natural GABA. However, 
some studies have found there to be no significant decrease in the number of receptors in those 
chronically exposed to benzodiazepines. Therefore, other theories attribute the ineffectiveness of 
benzodiazepines to modification of the GABAA receptors rather than to a loss of those receptors.
Abuse By Abusers
The Abuse of Benzodiazepines by Those Who Abuse Other Substances
 According to the APA, the prevalence of those individuals dependent on benzodiazepines 
among substance-abusers was found to be significantly higher than  among the general population. 
Benzodiazepines are often used in conjunction with other drugs by those who seek to use drugs 
for recreational purposes. Approximately 80% of those who abuse benzodiazepines are polydrug 
abusers. In a study conducted among Australian heroin users, 91% of the two hundred and twenty-
two participants had used benzodiazepines. Of those who had used benzodiazepines, 67% were 
currently using the drug on a regular basis. In a study by the National Institute of Drug Abuse, 73% 
of heroin users used benzodiazepines weekly for more than one year. Those who abuse alcohol are 
also at risk of becoming dependent on other drugs such as benzodiazepines.
 In response to an article published in The American Journal of Addictions regarding the 
safety of prescribing benzodiazepines for the treatment of insomnia and anxiety in substance abuse 
patients, Edgar P. Nace of Texas Southwestern Medical School published his view in The Brown 
Digest of Addiction Theory and Application.  Dr. Nace argues that substance abuse patients are at a 
greater risk of abusing benzodiazepines than the general population and, therefore, doctors should 
use caution when prescribing the drug. He cites that in samples of known substance abusers, 10% 
of the sample population were dependant on benzodiazepines at the time and over 50% were abus-
ers of the drug. 
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 Benzodiazepines have varied uses for those who are addicted to other drugs. While few 
use benzodiazepines alone for recreational purposes, drug abusers may take benzodiazepines to 
boost the effects of opioids or to alleviate withdrawal symptoms. For example, some may take 
benzodiazepines between heroin “fixes” to dull the negative feelings such as anxiety which they 
may feel.  In cases where other drugs an abuser takes become unavailable, he may take benzodi-
azepines alone in high dosages to placate his cravings. Many abusers also state that they use ben-
zodiazepines to prolong the “high” they receive from taking recreational drugs such as heroin and 
cocaine. Alcoholics use benzodiazepines to alleviate anxiety which results from chronic alcohol 
intake as well as to produce the pleasurable effect induced by mixing the drug with alcohol. 
 Short-acting benzodiazepines are more commonly used by substance abusers who benefit 
from the drugs’ rapid effects. However, clonazepam, which has a long-half life, is also a known 
benzodiazepine “street drug,” so it would seem that the delayed effects characteristic of the drug 
do not deter abusers. In addition, lipophilic benzodiazepines, which have the ability to cross the 
blood-brain barrier, and other benzodiazepines which have shorter half-lives and are highly potent 
are usually preferred by substance abusers.  The Center for Substance Abuse Research notes that 
benzodiazepines are likely to be abused due to the sedative state which they induce. As all benzo-
diazepines are sedatives, every variety of the drug has some degree of potential for abuse.
Toxicity and Substance Abuse
 The different varieties of benzodiazepines available vary in potency. Alprazolam is ap-
proximately twenty times more potent than diazepam. Therefore, those who are prescribed 6mg 
of alprazolam daily, a common dosage in the United States, are taking the equivalent of 120mg of 
diazepam, which is considered a very high dose. Doctors are made aware of these differences as 
administering a drug with too high a potency can prove very harmful. However, those who take 
the benzodiazepines for recreational purposes are unaware of the different posed by different ben-
zodiazepines. Generic drugs sold on the street are often unmarked or inappropriately labeled and 
an overdose of flurazepam or temazepam can result in fatality (Ashton, 2002a). 
 Benzodiazepines have additive effects with other drugs with sedative actions including 
other hypnotics, some antidepressants (e.g. amitriptyline [Elavil], doxepin [Adapin, Sinequan]), 
major tranquillisers or neuroleptics (e.g. prochlorperazine [Compazine], trifluoperazine [Stela-
zine]), anticonvulsants (e.g. phenobarbital, phenytoin [Dilantin], carbamazepine [Atretol, Tegre-
tol]), sedative antihistamines (e.g. diphenhydramine [Benadryl], promethazine [Phenergan]), opi-
ates (heroin, morphine, meperidine), and, importantly, alcohol. Patients taking benzodiazepines 
should be warned of these interactions. If sedative drugs are taken in overdose, benzodiazepines 
may add to the risk of fatality (Ashton, 2002b). 
Adverse Effects in the Elderly
 The risks normally posed by benzodiazepines are amplified in elderly populations. The 
negative effects which result from combining benzodiazepines with other drugs are more likely 
to surface in elderly patients who commonly take other medications regularly. In addition, elderly 
patients are more sensitive to dosage and, therefore, can more easily fall prey to the dangers associ-
ated with taking benzodiazepines which are too potent. Psychomotor skills are affected by benzo-
diazepines, thus slowing the body’s responses. This can be very detrimental in elderly patient who 
may have slower responses even without taking the drug. An increased number of hip fractures and 
falls in elderly patients have been attributed to benzodiazepine use.  
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 The effectiveness of benzodiazepines is found to be lower in elderly patients, while the 
negative effects are increased. Therefore, when it comes to the elderly, the drug is recommended 
for short term use only. In practice, however, benzodiazepines are usually prescribed to the elderly 
long-term.  Despite the guidelines which have been instated as a result of much research, 80% of 
elderly benzodiazepine patients receive treatments for over two years. (Note: Long-term use is 
defined as treatment lasting more than two weeks.) Benzodiazepines can offer much needed relief 
for sleep disorders, so it is not surprising that those receiving the treatment and benefitting from the 
drug would not want to stop taking it. In addition, many elderly patients would prefer to continue 
taking the medication rather than suffer from the withdrawal symptoms which they would experi-
ence if the drug’s administration were discontinued.
Falls and Fractures
 While many associate benzodiazepine use with hip fractures and injurious falls, the studies 
conducted have not provided consistent conclusions. A study conducted in France hoped to resolve 
this conflict by following a very large population of those over sixty-five years of age for up to ten 
years. 
 In this study, the individuals who qualified had experienced an injurious fall.  An injurious 
fall was defined as one which resulted in hospitalization, fractures, head trauma, or fatality. Con-
trols were selected at random from the numerous eligible subjects available.  The mean age of the 
sample was seventy-eight. For the purposes of analyzing results, the group was divided between 
those above eighty years of age and those below the age of eighty. A very significant correlation 
was found between benzodiazepine use and injurious falls in those above the age of eighty. “The 
population attributed risk of benzodiazepine use on injurious falls in subjects aged >80 years was 
estimated using an aged-stratified model as 28.1%.” Those conducting the study estimated that 
should the rate of injurious falls in the general population of France mirror the statistics found in 
their study, 71,000 injurious falls could be expected every year in those >80 years . Of those falls 
20,000 would be related to benzodiazepine use. Of those 20,000 falls, 1,800 would be fatal. In 
those below the age of eighty a strong correlation could not be defined (Pariente, et al., 2008).
 In a study conducted by Dr. Bula, of Cntre Hospitalier Universitaire, Lausanne, Switzer-
land, no correlation was found between injury and those using benzodiazepines chronically as 
opposed to those who were non-chronic users. Dr. Bula’s team followed 304 patients above the 
age of seventy-five for a six month period.  However, chronic users of benzodiazepines were noted 
more likely to become delirious during their stay in the hospital. As mental impairment is one of 
the negative side effects associated with benzodiazepine use, it is possible that the chronic users 
also experienced other negative side effects which went unobserved by Dr. Bula’s team.
“Driving Under the Influence”
 As benzodiazepines are known to affect cognition, especially in elderly populations, driv-
ing under the influence of benzodiazepines has become an issue. The rate of car accidents per 
mile involving elderly people is double than of those who are middle aged. Slowed reaction time, 
impaired joints, and vision problems are often to blame. A study conducted by McGill University 
in Montreal brought attention to a new culprit. The study examined the driving records and related 
documents of 225,000 people between the ages of 67 and 84. A rate increase of 45% was found in 
the number of car accidents resulting in injury involving those who had started taking benzodiaz-
epines within the week prior to the accident. It is thought that during this time the patients were 
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still adjusting to the side effects of the drug such as daytime drowsiness and overall slower motor 
coordination. However, even among those who had assumedly already adjusted to the medication, 
the rate of accident was 26% higher among those taking benzodiazepines for as long as one year 
than those not receiving the medication. In addition, long-lasting benzodiazepines which linger 
in the blood stream for longer periods of time were related to higher rates of accidents (“Driving 
Under the Influence,” 1997). 
Of Doctors and Dependence
 Doctors’ disregard for the guidelines of benzodiazepine administration can lead to many 
negative side effects including toxicity, difficulty sleeping, falls, and impaired motor skills. Un-
fortunately, doctors commonly continue to prescribe benzodiazepines to their elderly patients al-
though they are only recommended for short-term use.
  In a unique study conducted by a collaboration of doctors and professors from various 
parts of the United States, doctors were questioned about their seemingly irresponsible practice. 
Their reasoning was usually centered on the fact that their patients were old and in need of peace 
or sleep, and the doctors were sought to provide whatever relief they could. They were not very 
concerned with the patients becoming dependent or addicted, as many doctors felt that little harm 
would come if their patients could continue to take safe dosages of benzodiazepines for the rest 
of their lives. Others feared that stopping a patient’s benzodiazepine supply would cause them to 
lose the patient. They believed that a patient who is accustomed to taking a certain benzodiazepine 
would simply switch to another doctor who would provide the desired prescription. Below are 
some of the more memorable responses provided by the doctors as to why they continually pre-
scribe benzodiazepines despite the risks:
 “You’d like to say, well, I can just put a great big brick wall in front of me and the patient 
with benzodiazepines but it doesn’t work that way,,. You feel like you’ve gotta give the patient 
something to help.”
 “It’s literally like taking candy from a baby and people that have enjoyed the effects of that 
class of drugs don’t wanna give it up. I can’t lose patients over this.”
 “It’s just so much easier to just prescribe something and just walk away.”
 “I’m not worried about fifteen or twenty years down the road I’m gonna still be giving her 
Ativan. She’s not gonna be alive in twenty years down the road and I’m sort of surprised she’s 
alive now... She really needs it. If it helps her get through her days better, great.”
 All the doctors interviewed were aware that there were additional risks involved in pre-
scribing benzodiazepines to elderly patients. Many of the doctors interviewed seemed to be mak-
ing their decisions on moral grounds rather than on scientific ones. While some find fault in the 
practices of these doctors, many actually agree with their practices believing that if monitored, 
benzodiazepine dependence can benefit the patient while doing minimal harm (Cook, et al., 2007).
CONCLUSION
 In order to prevent the negative side effects associated with long-term exposure, benzodi-
azepines should not be administered or taken for extended periods of time. Patients should adhere 
to the dosages prescribed by their doctors and not seek to increase their doses or obtain additional 
dosages from other sources.  In the event that a patient does become dependent on benzodiaz-
epines, dosages should be reduced gradually. Long-acting drugs may be replaced by short-acting 
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ones to aid the gradual withdrawal process. Anti-convulsants are also used to curb anxiety which 
may arise as a result of withdrawal. These methods of weaning a patient off of benzodiazepines 
can minimize the backlash of symptoms which usually accompany withdrawal. 
 While most authorities claim that benzodiazepines are rarely abused by the general popula-
tion, those who abuse other substances are highly susceptible to abusing benzodiazepines. Doctors 
are warned to take care when prescribing benzodiazepines to substance abusers; some even sug-
gest that doctors avoid prescribingit to that demographic altogether. If a patient who is a substance 
abuser must be prescribed benzodiazepines, his intake should be carefully monitored.
 Elderly patients are believed to be more susceptible to the side-effects associated with 
taking benzodiazepines. Therefore, additional care should be taken to ensure they receive proper 
dosages. The effects the drug may have on the patient should be observed in order to evaluate if 
the patient is able to drive safely and perform other daily tasks unimpeded.
 As benzodiazepines are highly beneficial and an effective treatment for the treatment of 
insomnia and anxiety, they should be prescribed for the general public. However, extra care should 
be taken when prescribing the drug to those demographics which are additionally susceptible to 
the negative side-effects and risks posed by the use of benzodiazepines. 
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